Guyana vs Paraguay: Incidence of tuberculosis
Incidence of tuberculosis over time
- Guyana
- Paraguay
How they compare
Paraguay currently reports 81 per 100,000 people against 67 per 100,000 people in Guyana, a difference of 14 per 100,000 people.
That makes Paraguay's figure about 1.2 times Guyana's.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Guyana ahead.
Guyana ranks 73rd and Paraguay ranks 71st of 208 countries.
Across the 3 decades both report, Guyana averaged higher in 2 and Paraguay in 1.
Head to head by decade
| Decade | Guyana | Paraguay | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 153.2 per 100,000 people | 83 per 100,000 people | 70.2 per 100,000 people | Guyana |
| 2010s | 113.1 per 100,000 people | 57.9 per 100,000 people | 55.2 per 100,000 people | Guyana |
| 2020s | 63.8 per 100,000 people | 66.2 per 100,000 people | 2.4 per 100,000 people | Paraguay |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher incidence of tuberculosis, Guyana or Paraguay?
- Paraguay, at 81 per 100,000 people against 67 per 100,000 people in Guyana as of 2024.
- What is the difference in incidence of tuberculosis between Guyana and Paraguay?
- 14 per 100,000 people, with Paraguay ahead.
- How many years of comparable data are there for Guyana and Paraguay?
- 25 years are reported by both, from 2000 to 2024.
- How do Guyana and Paraguay rank globally for incidence of tuberculosis?
- Guyana ranks 73rd and Paraguay ranks 71st of 208 countries.
- Where does this data come from?
- Global Tuberculosis Report, World Health Organization (WHO), published as Incidence of tuberculosis (per 100,000 people). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Incidence of tuberculosis is the estimated number of new and relapse tuberculosis cases arising in a given year, expressed as the rate per 100,000 population. All forms of TB are included, including cases in people living with HIV. Estimates for all years are recalculated as new information becomes available and techniques are refined, so they may differ from those published previously.